Hormonal
Maintaining weight loss after formula diet-induced weight loss requires specific strategies, including continued use of formula products, behavioral support, and gradual food reintroduction, as physiological hunger hormones (ghrelin) increase post-weight loss.
After losing weight with formula meals, your body will naturally try to regain it by increasing hunger hormones. To keep the weight off, you must actively maintain your progress. This means continuing to use some formula products (daily or periodically), engaging in behavioral strategies like self-monitoring, and slowly reintroducing solid foods over 6 weeks rather than rushing back to normal eating.
Weight regain following the initial TDR phase of formula VLEDs and LEDs is common without additional support... Following weight loss on a VLED, a compensatory increase in subjective hunger has been reported and associated with higher circulating levels of ghrelin... Recent well-controlled studies suggest that weight loss maintenance is possible with the addition of several key strategies... continued use of formula products either daily (1–2 products per day) or intermittently... has been shown to aid weight maintenance for up to 4 years.
Why this rating
Supported by multiple controlled trials and systematic reviews on maintenance strategies.
Source
Very low‐energy and low‐energy formula diets: Effects on weight loss, obesity co‐morbidities and type 2 diabetes remission – an update on the evidence for their use in clinical practice
Adrian Brown et al. · Nutrition Bulletin · 2019
DOI 10.1111/nbu.12372
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →